Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Primary pulmonary hypertension (PPH) is a condition of unknown cause that is characterized by increasing pulmonary arterial and vascular resistance. Treprostinil is a stable analog of prostacyclin that is used clinically for the treatment of PPH under the trade name Remodulin®. The structural modifications in treprostinil compared to prostacyclin increase the plasma half-life from 2 minutes to 34 and 85 minutes for intravenous and subcutaneous infusion of the drug, respectively.1 In addition to treprostinil’s direct vasodilatory effects, it also inhibits inflammatory cytokine (TNFα, IL-1β, IL-6, GM-CF) production by human alveolar macrophages in the sub-micromolar range by preventing NF-κB translocation to the nucleus.2
1
Olschewski, H., Rose, F., Schermuly, R., et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther102139-153(2004).
2
Raychauduri, B., Malur, A., Bonfield, T.L., et al. The prostacyclin analogue treprostinil blocks NFκB nuclear translocation in human alveolar macrophages. J Biol Chem277(36)33344-33348(2002).
Olschewski, H., Rose, F., Schermuly, R., et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther102139-153(2004).
Raychauduri, B., Malur, A., Bonfield, T.L., et al. The prostacyclin analogue treprostinil blocks NFκB nuclear translocation in human alveolar macrophages. J Biol Chem277(36)33344-33348(2002).
Treprostinil is available in the following screening
libraries: